Low Risk of Severe Complications After a Single, Post-Operative Instillation of Intravesical Chemotherapy in Patients with TaG1G2 Urothelial Bladder Carcinoma [0.03%]
TaG1G2期尿路上皮膀胱癌患者术后单次膀胱灌注化疗严重并发症发生率低
Lisa M C van Hoogstraten,J Alfred Witjes,Theodora M Ripping et al.
Lisa M C van Hoogstraten et al.
Background: EAU guidelines recommend a single instillation (SI) of intravesical chemotherapy (e.g. Mitomycin C) within 24 hours after transurethral resection of a bladder tumour (TURBT) in patients with low- to intermedia...
Piyush K Agarwal,Cora N Sternberg
Piyush K Agarwal
Thromboembolism in Muscle-Invasive Bladder Cancer. A Population-based Nationwide Study [0.03%]
肌肉侵袭性膀胱癌的血栓栓塞：基于全国人口的队列研究
Staffan Jahnson,Truls Gårdmark,Abolfazl Hosseini et al.
Staffan Jahnson et al.
Background: Routine VTE prophylaxis within 30 days of radical cystectomy (RC) for urinary bladder cancer (UBC) is used to protect from venous thromboembolism (VTE). However, randomized studies and nationwide population-ba...
A Systematic Review of Outcome Reporting, Definition and Measurement Heterogeneity in Non-Muscle Invasive Bladder Cancer Effectiveness Trials of Adjuvant, Prophylactic Treatment After Transurethral Resection [0.03%]
系统评价：非肌层浸润性膀胱癌经尿道切除术（TURBT）后辅助或预防治疗的有效性试验的结局报告、定义及测量异质性
Erik Veskimae,Selvarani Subbarayan,Riccardo Campi et al.
Erik Veskimae et al.
Background: Heterogenous outcome reporting in non-muscle-invasive bladder cancer (NMIBC) effectiveness trials of adjuvant treatment after transurethral resection (TURBT) has been noted in systematic reviews (SRs). This hi...
Significance and Mechanisms Analyses of RB1 Mutation in Bladder Cancer Disease Progression and Drug Selection by Bioinformatics Analysis [0.03%]
生物信息学分析RB1基因突变在膀胱癌疾病进展和药物选择中的意义及机制分析
Dingguo Zhang,Jinjun Tian,Qier Xia et al.
Dingguo Zhang et al.
Background: Bladder cancer is still a disease of significant morbidity and mortality. In bladder cancer, RB1 is one of the most common mutant genes. Metho...
Single Instillation of Hypertonic Saline Immediately Following Transurethral Resection of Bladder Tumor for Recurrence Prevention -A Phase I Study [0.03%]
单次输注高渗盐水用于预防膀胱肿瘤经尿道切除术后复发的I期研究
Jonathan Modai,Alexey Kovalyonok,Avigdor Scherz et al.
Jonathan Modai et al.
Background: Urologic guidelines recommend perioperative instillation of chemotherapy after transurethral resection of bladder tumor (TURBT) to decrease tumor recurrence, yet implementation of this recommendation is partia...
Spectrum of FGFR2/3 Alterations in Cell-Free DNA of Patients with Advanced Urothelial Carcinoma [0.03%]
晚期尿路上皮癌患者血浆游离DNA中FGFR2/3变异的检测及其临床意义分析
Petros Grivas,Lesli A Kiedrowski,Guru P Sonpavde et al.
Petros Grivas et al.
Detecting genomic alterations (GAs) in advanced urothelial carcinoma (aUC) can expand treatment options by identifying candidates for targeted therapies. Erdafitinib is FDA-approved for patients with platinum-refractory aUC with activating ...
Benefit of Adjuvant Chemotherapy After Radical Cystectomy for Treatment of Urothelial Carcinoma of the Bladder in the Elderly -An International Multicenter Study [0.03%]
根治性膀胱切除术治疗老年膀胱尿路上皮癌术后辅助化疗的收益：一项国际多中心研究
Victor M Schuettfort,Benjamin Pradere,Hadi Mostafaei et al.
Victor M Schuettfort et al.
Background: Radical cystectomy (RC) is the standard treatment for muscle invasive bladder cancer, but approximately half of all patients will ultimately succumb to disease progression despite apparent cure with extirpativ...
Rationale for Randomized Clinical Trials Investigating the Potential of BCG Vaccination in Preventing COVID-19 Infection [0.03%]
BCG疫苗预防COVID-19感染的随机临床试验的设计理由
Magali Noval Rivas,Charles J Rosser,Moshe Arditi
Magali Noval Rivas
Despite the implementation of mitigation measures, Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is still spreading worldwide, and has caused more than 1 million deaths so far. ...
Mark S Soloway
Mark S Soloway